A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

This is a safety and efficacy study of Keppra® extended release formulation - XR in patients with epilepsy.

Phase 3

UCB Pharma

Etiracetam
Levetiracetam